Philips strengthens its offer to diagnosis of sleep through the acquisition of the business of the NAP group auto medición.

Amsterdam, Netherlands and Austria, February 2010.- Royal Philips Electronics (AEX: PHI, NYSE: PHG) announced the acquisition of the business of providing automated solutions score Somnolyzer 24 x 7 by the Group NAP in Vienna. This solution approved by the FDA and based on the most advanced technology and automatic score clinically tested in the market, will help to improve the productivity of the dream centres. The NAP group is a company clinical and research dedicated to software and specialized in solutions for measurement of polysomnography for sleep centers. The new acquisition will be integrated within part of the business of diagnoses of the dream within Philips Home Healthcare Solutions.

With the increase in the demand for evidence of sleep disorders, sleep, physical and technical centres need tools and services that offer a consistent and efficient improved measurement enabling them to focus on those parts of the study of sleep and other activities that require professional experience ”, said Don Spence, CEO of Philips Home Healthcare Solutions. Somnolyzer 24 x 7 solution is a strategic added value for the supply of diagnosis of the dream of Philips that allows us to offer a productivity improved in the sleep laboratory and directing further growth of the diagnosis of sleep for our customers and our business ”.

Expected that diagnostic sleep tests continue to grow in the coming years with a growing global awareness on the disorders of sleep such as Obstructive Sleep Apnea (OSA). In developed markets, the automatic measurement technology represents an opportunity to improve the productivity of the dream centres. This automated measurement technology can also allow arising centres of sleep in emerging markets to deal with the challenges of the increase in the demand for tests of the dream and the shortage of specialists of the dream.

The acquisition of the business of the NAP group auto-medición will further strengthen Philips leadership in the area of strategic growth of health care at home, holding the company’s expansion in the markets at the global level in the diagnosis of sleep and therapies SAOS.

The business of research and clinical testing services, which are not part of the acquisition, will remain and will continue in the Siesta group, based in Vienna.

* Polysomnography (PSG), also known as a dream studio, is a comprehensive recording of brain waves, eye movements, muscle activity, heart rate and breathing during sleep, used as a diagnostic tool in sleep medicine.

Royal Philips Electronics

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a company whose activities cover all aspects of the care of the health and well-being, with the aim of improving the quality of life of people offering them the necessary innovations at the right time. As a leader in the health care, consumer and lifestyle, and lighting, Philips integrates the most advanced technologies and the latest design solutions always developed around the needs of the people and based on a profound knowledge of the consumer and your brand promise sense and simplicity ”. Headquartered in the Netherlands, Philips has a staff of approximately, 116.000 employees in over 60 countries. With a turnover of 26 billion euros in 2008, the company is world leader in systems for critical care and heart, and Telemonitoring in lighting solutions based on energy efficiency and new lighting applications, and consumer solutions to improve the quality of life and the variety of leisure activities of people, with a strong leadership position in flat TVs, shaving and men’s toilet, portable entertainment and oral care systems.